MetaCap

Tyra Biosciences Balance Sheet

NASDAQ: TYRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

19.94-0.03 (-0.15%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Tyra Biosciences financial position

At the end of fiscal 2025, Tyra Biosciences reported total assets of $282.6 million, down 22.3% from a year earlier against total liabilities of $23.4 million. Shareholders' equity stood at $259.2 million, or 91.7% of assets. The company held $77.4 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 14.67, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Tyra Biosciences balance sheet (annual)

Tyra Biosciences annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31
Cash & Equivalents77.39M91.97M58.01M251.21M302.18M15.22M
Total Current Assets265.45M347.46M211.67M257.29M304.06M15.28M
Property, Plant & Equipment1.31M1.65M1.63M1.08M1.03M297.00K
Total Assets282.61M363.56M225.86M266.18M306.70M16.01M
Accounts Payable1.18M590.00K4.66M1.15M599.00K664.00K
Total Current Liabilities18.09M14.59M15.33M5.70M3.62M1.86M
Total Liabilities23.43M20.41M21.59M8.35M4.96M2.00M
Shareholders' Equity259.18M343.15M204.26M257.83M301.74M-13.64M
Retained Earnings-371.26M-251.31M-164.83M-95.70M-40.37M-14.08M
Net Cash (Debt)77.39M91.97M58.01M251.21M302.18M15.22M
Shares Outstanding53.71M50.75M43.02M42.35M41.44M1.83M

This table shows 6 annual periods of Tyra Biosciences's balance sheet, from FY 2025 back to FY 2020, across 11 line items including cash & equivalents, total current assets, property, plant & equipment. Values in USD; B = billions, M = millions. Fiscal periods follow TYRA's reporting calendar. What is a balance sheet?

More financial data